2021
Sep - NIH Phase 1 grant to develop Alzheimer’s (tauopathies) therapy
Jul - Closes initial Seed round led by Two Bear Capital
Sep - NIH Phase 1 grant to develop Alzheimer’s (tauopathies) therapy
Jul - Closes initial Seed round led by Two Bear Capital